Matthew S. Choo

Matthew S. Choo

Auto-generated profile, based on publicly available information

Matthew S. Choo

Analytics Group, Bioprocessing Technology Institute, Agency for Science, Technology and Research, Singapore, Singapore

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Nature Methods
Verified
Journal Article
Open access
PDF file
RKRebeca Kawahara
Rebeca Kawahara
ACAnastasia Chernykh
Anastasia Chernykh
KAKathirvel Alagesan
Kathirvel Alagesan
MBMarshall Bern
Marshall Bern
WCWeiqian Cao
Weiqian Cao
MTMorten Thaysen-Andersen
Morten Thaysen-Andersen
Glycoproteomics is a powerful yet analytically challenging research tool. Software packages aiding the interpretation of complex glycopeptide tandem mass spectra have appeared, but their relative performance remains untested. Conducted through the HUPO Human Glycoproteomics Initiative, this community study, comprising both developers and users of glycoproteomics software, evaluates solutions for system-wide glycopeptide analysis. The same mass spectrometry based glycoproteomics datasets from human serum were shared with participants and the relative team performance for N- and O-glycopeptide data analysis was comprehensively established by orthogonal performance tests. Although the results were variable, several high-performance glycoproteomics informatics strategies were identified. Deep analysis of the data revealed key performance-associated search parameters and led to recommendations for improved ‘high-coverage’ and ‘high-accuracy’ glycoproteomics search solutions. This study concludes that diverse software packages for comprehensive glycopeptide data analysis exist, points to several high-performance search strategies and specifies key variables that will guide future software developments and assist informatics decision-making in glycoproteomics.

14 November 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
CCChristine Lin Chin
Christine Lin Chin
JGJustin Bryan Goh
Justin Bryan Goh
HSHarini Srinivasan
Harini Srinivasan
KLKaiwen Ivy Liu
Kaiwen Ivy Liu
AGAli Gowher
Ali Gowher
SNSay Kong Ng
Say Kong Ng
Mammalian host cell lines are the preferred expression systems for the manufacture of complex therapeutics and recombinant proteins. However, the most utilized mammalian host systems, namely Chinese hamster ovary (CHO), Sp2/0 and NS0 mouse myeloma cells, can produce glycoproteins with non-human glycans that may potentially illicit immunogenic responses. Hence, we developed a fully human expression system based on HEK293 cells for the stable and high titer production of recombinant proteins by first knocking out GLUL (encoding glutamine synthetase) using CRISPR-Cas9 system. Expression vectors using human GLUL as selection marker were then generated, with recombinant human erythropoietin (EPO) as our model protein. Selection was performed using methionine sulfoximine (MSX) to select for high EPO expression cells. EPO production of up to 92700 U/mL of EPO as analyzed by ELISA or 696 mg/L by densitometry was demonstrated in a 2 L stirred-tank fed batch bioreactor. Mass spectrometry analysis revealed that N-glycosylation of the produced EPO was similar to endogenous human proteins and non-human glycan epitopes were not detected. Collectively, our results highlight the use of a human cellular expression system for the high titer and xenogeneic-free production of EPO and possibly other complex recombinant proteins.

13 May 2019 in Analytical Chemistry
Verified
Journal Article
Closed access
MCMatthew S. Choo
Matthew S. Choo
CWCorrine Wan
Corrine Wan
PRPauline M. Rudd
Pauline M. Rudd
TNTerry Nguyen-Khuong
Terry Nguyen-Khuong

9 November 2020 in Analytical Chemistry
Verified
Journal Article
Closed access
EPEdward G. Pallister
Edward G. Pallister
MCMatthew S. F. Choo
Matthew S. F. Choo
IWIan Walsh
Ian Walsh
JTJien Nee Tai
Jien Nee Tai
STShi Jie Tay
Shi Jie Tay
TNTerry Nguyen-Khuong
Terry Nguyen-Khuong

1 April 2017 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
MCMatthew Choo
Matthew Choo
HTHeng Liang Tan
Heng Liang Tan
VDVanessa Ding
Vanessa Ding
RCRoberto Castangia
Roberto Castangia
OBOmar Belgacem
Omar Belgacem
ACAndre Choo
Andre Choo
Cancer-specific glycans of ovarian cancer are promising epitopes for targeting with monoclonal antibodies (mAb). Despite their potential, structural characterization of these glycan epitopes remains a significant challenge in mAb preclinical development. Our group generated the monoclonal antibody mAb-A4 against human embryonic stem cells (hESC), which also bound specifically to N-glycans present on 11 of 19 ovarian cancer (OC) and 8 of 14 breast cancer cell lines tested. Normal cell lines and tissue were unstained by mAb-A4. To characterize the N-linked glycan epitopes on OC cell lines targeted by mAb-A4, we used glycosidases, glycan microarray, siRNA, and advanced high sensitivity matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS). The mAb-A4 epitopes were found to be Fucα1–2Galβ1–3GlcNAcβ (H type 1) and Galβ1–3GlcNAcβ (type 1 LacNAc). These structures were found to be present on multiple proteins from hESC and OC. Importantly, endo-β-galactosidase coupled with MALDI-MS allowed these two epitopes, for the first time, to be directly identified on the polylactosamines of N-glycans of SKOV3, IGROV1, OV90, and OVCA433. Furthermore, siRNA knockdown of B3GALT5 expression in SKOV3 demonstrated that mAb-A4 binding was dependent on B3GALT5, providing orthogonal evidence of the epitopes' structures. The recognition of oncofetal H type 1 and type 1 LacNAc on OC by mAb-A4 is a novel and promising way to target OC and supports the theory that cancer can acquire stem-like phenotypes. We propose that the orthogonal framework used in this work could be the basis for advancing anti-glycan mAb characterization.

24 June 2020 in Analytical Chemistry
Verified
Journal Article
Closed access
SLSteffen Lippold
Steffen Lippold
ABAlexander Büttner
Alexander Büttner
MCMatthew S.F. Choo
Matthew S.F. Choo
MHMichaela Hook
Michaela Hook
CJCoen J. de Jong
Coen J. de Jong
NHNoortje de Haan
Noortje de Haan